-
9
Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of alpha-1 antitrypsin deficiency; downloadable multimedia files containing artwork, text, audio and video relating to alpha-1 antitrypsin deficiency; pre-recorded electronic media in the field of alpha-1 antitrypsin deficiency
-
16
Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
printed informational and educational materials, namely, booklets and reference guides, in the field of alpha-1 antitrypsin deficiency
-
36
Insurance; financial affairs; monetary affairs; real estate affairs
charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by alpha-1 antitrypsin deficiency
-
41
Education; providing of training; entertainment; sporting and cultural activities
education services, namely, providing classes, seminars, and workshops in the field alpha-1 antitrypsin deficiency; providing on-line publications in the nature of guides and newsletters in the field of alpha-1 antitrypsin deficiency; training of study staff in the field of alpha-1 antitrypsin deficiency and clinical trials
-
42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software
providing medical and scientific research information in the field of alpha-1 antitrypsin deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by alpha-1 antitrypsin deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes
-
44
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
health care services, namely, disease management for individuals affected by alpha-1 antitrypsin deficiency; providing support and assistance services to inform individuals affected by alpha-1 antitrypsin deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of alpha-1 antitrypsin deficiency; providing health and medical care information to individuals affected by alpha-1 antitrypsin deficiency about the range of possible diagnoses and therapies to improve the quality of their lives, providing support and assistance in the nature of health and wellness counseling to individuals affected by alpha-1 antitrypsin deficiency
-
45
Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals
providing support and assistance in the nature of counseling to individuals affected by alpha-1 antitrypsin deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes